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Description

Left ventricular non-compaction cardiomyopathy is an uncommon type of cardiomyopathy
caused by malformation of the myocardium during embryogenesis. This results in trabeculations within the ventricular wall that can affect the left and, less commonly, right ventricles.
Presentation ranges from clinically asymptomatic to life-threatening arrhythmias. It is a
rare and relatively unknown form of cardiomyopathy, though thought to be underdiagnosed. Prevalence is increasing due to improvements in imaging and awareness. Management is similar to that of other cardiomyopathies including angiotensin-converting-enzyme
inhibitors or angiotensin receptor blockers, beta-blockers, diuretics, automatic implantable
cardioverter defibrillator placement and cardiac transplantation. We present a case of a
38-year-old, otherwise healthy, Indian male who presented with flash pulmonary edema and
was found to have left ventricular non-compaction cardiomyopathy. This report includes a
review of left ventricular non-compaction cardiomyopathy.
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Introduction

Left ventricular non-compaction cardiomyopathy (LVNC), also known as non-compaction
cardiomyopathy or spongiform cardiomyopathy, is a rare phenotype of cardiomyopathy. Sporadic and inherited forms have been
described. Bellet and Gouley first described
characteristics of LVNC in 1932 after a newborn
autopsy.1 Dusek et al. later described the postnatal persistence of intertrabecular spaces and
sinusoids seen in LVNC in histologic sections of
postmortem analysis of stillborns, newborns
and infants.2 In 1984, echocardiographic features of LVNC were described by Engberding
and Bender.1,3 Diagnosis remains challenging,
with no universal criteria established. Here we
report a case of LVNC presenting as flash pulmonary edema and heart failure, review common diagnostic criteria and discuss principles
of management.

Case Description

A 38-year-old Indian male with no significant
medical history presented to a freestanding
emergency room complaining of shortness of
breath and a cough productive of pink, frothy
sputum. Upon initial examination, he was found
to have two-word dyspnea, elevated blood
pressure and tachycardia. A chest x-ray was significant for bilateral airspace disease. He was
placed on non-invasive positive pressure ventilation and given intravenous furosemide and
ceftriaxone. His respiratory status continued to
decline, and he was intubated prior to transfer
to our hospital. He was admitted to the intensive care unit where vasopressor support and
broad-spectrum intravenous antibiotics were
initiated.
Laboratory studies were significant for elevated lactic acid (3.7 mmol/L), leukocytosis (26.6/
μL), elevated troponin (0.093 ng/ml, peaked at
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Figure 1. Apical 4-chamber view demonstrating classic non-compaction cardiomyopathy appearance with prominent trabeculations and intertrabecular recesses.
0.471 ng/ml), and a pro-BNP of 1090 pg/ml. An
electrocardiogram revealed sinus tachycardia.
Initial echocardiogram showed mild concentric
left ventricular hypertrophy, left ventricular
ejection fraction of 28%, diffuse left ventricular hypokinesis and grade 3 diastolic dysfunction. Increased trabeculations and blood flow
through intertrabecular recesses within the
apex of the left ventricle were also noted.
(Figure 1) Non-compaction to compaction
(NC/C) ratio of 2.1 was consistent with noncompaction cardiomyopathy by Zurich criteria.
(Figure 2)

Discussion

Left ventricular non-compaction cardiomyopathy (LVNC) results from abnormal embryogenesis of the myocardium. Development of
the heart in utero begins with a meshwork of

muscle fibers and trabeculations that allow
blood flow to the ventricle before coronary vasculature develops. Once coronary vessels form,
the trabeculated myocardium compacts into
a smooth endocardial surface.4 LVNC results
from failure of this transition, which normally
occurs in the 12th to 18th week of embryogenesis. This results in the formation of a thickened
endomyocardial layer with deep recesses, trabeculae that are continuous with the left ventricular cavity and a thin compacted epicardial
layer.1, 3-5 Similar sinusoidal phenotypes can be
seen in association with other inherited heart
defects, such as pulmonary atresia. In isolated
LVNC, sinusoids do not communicate with the
epicardial circulation and are present primarily
in the apex and lateral walls of the heart.6-7
Sporadic and inherited forms of LVNC have
been described. LVNC is inherited in 15-20% of

Figure 2. Parasternal short axis view showing >2:1 ratio of non-compacted to compacted myocardium. End-systole. (Zurich criteria)
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cases and more commonly identified in childhood.5-6 Patients diagnosed at infancy are often
more severely affected.5 Among the inherited
forms, X-linked, autosomal dominant, autosomal recessive and mitochondrial inheritance
have been reported. Implicated genes code sarcomeric, cytoskeletal and ion channel proteins.4
Sarcomeric gene mutations MYH7, MYBPC3,
ACTC1, LDB3, TNNT2, and TPM1 are known to
cause LVNC.8 Cytoskeletal genes implicated include DTNA and LMNA. HCN4 and SCN5A are
the known LVNC-causing ion-channel gene mutations. Additionally, associated genes include
MIB1, PRDM16 and TAZ.8 Familial LVNC often
co-exists with neuromuscular disorders, such as
Barth syndrome and myotonic dystrophies.3-5
Cases of LVNC have been identified in utero
to the 10th decade of life, and males appear
to be predominantly affected.9 Prevalence is
estimated to range from 0.014% to 0.24% and
up to 3–4% in all patients with heart failure.9-11
Increase in incident cases is potentially related
to improved clinical recognition and diagnosis
due to higher resolution in imaging modalities,
such as cardiac magnetic resonance imaging
(CMR) and widespread awareness of the clinical entity.11
LVNC presentation can vary from clinically
asymptomatic to fatal arrhythmias. Findings
at presentation can include systolic or diastolic heart failure, arrhythmia and systemic
thromboemboli.4,12 Asymptomatic patients are
identified incidentally upon cardiac imaging or
after referral for genetic testing.11 Presence of
ventricular arrhythmia is estimated at 2–62%
and roughly 40% in children.4,13 The incidence of
sudden cardiac death varies between 6–23%.2,14
Systemic thromboemboli are more common in
LVNC than other cardiomyopathies, affecting
between 5-38% of patients with an event rate
of 1–2% per year.3-5
Diagnosis of LVNC is made through echocardiography, CMR or cardiac computed tomography (CT). Electrocardiogram findings support
this diagnosis but are not confirmatory.1,3 There
are currently no universal criteria for diagnosis.
Echocardiography is historically the imaging
modality of choice.13,15 The two most widely
used sets of diagnostic tools are the California and the Zurich criteria. Both require the

absence of coexisting cardiac anomalies and
the presence of a bilayered endomyocardium
with a thickened, non-compacted layer and a
thin compacted layer.10,12,16 The California criteria
focuses on posterior wall thickness to depth of
recesses at end-diastole while the Zurich criteria measures non-compaction to compaction
(NC/C) ratio at end-systole.9-11 The Vienna criteria requires images at both end-systole and
end-diastole.17 The Milwaukee criteria compares
the NC/C layer in various windows and cardiac
cycles.18 These criteria are illustrated in Table 1.
CMR provides added information in patients
with technically difficult or limited ultrasound
studies and allows better visualization of the
left ventricular apex and detection of myocardial fibrosis using late gadolinium enhancement.1,3
A proposed CMR criteria for the diagnosis of
LVNC is a NC/C ratio of greater than 2.3 in
diastole.19 Cardiac CT can be used to assess
concurrent coronary artery disease (CAD) in
low-risk CAD patients.3
Management is based on the pathologic symptomatology of the disease. In asymptomatic
patients, clinical follow-up may be the only
management necessary.1 Heart failure and
arrhythmias are treated according to existing
evidence-based guidelines, which include cardiac transplantation in appropriate patients with
disease that is refractory to medical therapy.
Anticoagulation in LVNC is a debated topic. Anticoagulation should be considered in patients
thought to be at elevated risk for thromboembolism, such as those with LV dysfunction or
prior embolic events. Anticoagulation should be
initiated for those in whom an atrial or ventricular thrombus is identified.1 While management
is unchanged when an LVNC-causing mutation
is found in an index patient, cascade genetic
testing is recommended and first-degree relatives should be evaluated.5
Our patient was treated with intravenous
diuretics and guideline-directed medical therapy for dilated cardiomyopathy, including sacubitril/valsartan. Cardiac catheterization was
performed after the patient’s volume status
stabilized, which revealed angiographically
normal coronary arteries and diffuse left ventricular hypokinesis. An automatic implantable
cardioverter defibrillator was recommended,
which the patient declined. Genetic testing and
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Table 1. Echocardiographic criteria for non-compaction cardiomyopathy.
Chin et al.12,16,18
Jenni et al.10,18
Stöllberger et al.18 Paterick et al.17,18
(California
(Zurich criteria)
(Vienna criteria)
(Milwaukee
criteria)
criteria)
Echocardiogram Parasternal
view
short-axis and
apical views

Short-axis views

End-systolic and
end-diastolic
images must be
viewed

Bilayered myocardium should
be seen in the
following views:
•Short-axis view
at mid and apical
areas
•Apical 2- and
4-chamber views
•Apical long-axis
views

Criteria

•Multiple prominent trabeculations (primarily in
the apex, mid-lateral, and mid-inferior areas of the
left ventricular
wall)
•Non-compaction
to compaction
(NC/C) > 2.0 at
end-systole measured at maximal
wall thickness
•Color Doppler
imaging that
shows multiple
deep intertrabecular recesses
communicating
with the ventricular cavity

All 4 criteria must
be met:
•More than 3
prominent trabeculations along
the left ventricular wall seen in
end-diastole
•Trabeculations
should move with
the compacted
myocardium
•Trabeculations
are best seen in
end-systole
•Color Doppler
imaging that
shows perfusion
of intertrabecular
spaces at end-diastole

•NC/C > 2.0
at end-diastole; preferably
measured in the
short-axis views
•Abnormal ventricular function
and myocardial
mechanics

Ratio X/Y ≤ 0.5,
calculated at
end-diastole
Where:
•X = distance
from the epicardial surface to
the trough of the
trabecular recesses
•Y = distance
from the epicardial surface to
the peak of the
trabeculation

repeat imaging were recommended as well but,
the patient was lost to follow-up before these
procedures could be completed.

Conclusion

LVNC is a rare phenotype of cardiomyopathy
and must be considered when patients present
with symptoms of heart failure. Both sporadic
and inherited forms have been described. LVNC
presentation can vary from clinically asymptomatic to end-stage heart failure with sequelae
causing sudden cardiac death. Increase in cases
are likely due to improved clinical recognition.
LVNC diagnosis remains challenging, and no
universal criteria have been established. The
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two most widely used sets of diagnostic tools
are the California and Zurich criteria. Management is dependent upon the clinical presentation.
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